The cataract surgery technology landscape including pipeline products at varying development stages comes under scrutiny in a new report released this month.
ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight
Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile
Higher Molar Dose and Its Translation into Clinical Practice
Unite and conquer: Refractive surgery goes on a world tour
The ESCRS Moving Simulator initiative brings surgical training to nations in need
Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS
Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress
BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS
The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family
Corneal nerve regeneration following semaglutide therapy
A case report demonstrates independent effect of GLP-1 receptor agonist